AI-generated market updates and breaking coverage across our tracked tickers.
Eli Lilly (LLY) exhibits slight pre-market gains despite uncertainty around Medicare and self-pay dynamics. Recent news highlights a partnership with Nvidia and ongoing FDA scrutiny of weight loss drugs, presenting a complex outlook for investors.
